Publication Information

{'id': 'https://openalex.org/W2903848939', 'doi': 'https://doi.org/10.1634/theoncologist.2018-0084', 'title': 'FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy', 'display_name': 'FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy', 'publication_year': 2018, 'publication_date': '2018-12-12', 'ids': {'openalex': 'https://openalex.org/W2903848939', 'doi': 'https://doi.org/10.1634/theoncologist.2018-0084', 'mag': '2903848939', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/30541754', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/6459239'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.2018-0084', 'pdf_url': 'https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2018-0084', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2018-0084', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5040090615', 'display_name': 'Daniel L. Suzman', 'orcid': 'https://orcid.org/0000-0002-1702-6114'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Daniel L. Suzman', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072533439', 'display_name': 'Sundeep Agrawal', 'orcid': 'https://orcid.org/0000-0002-5447-8590'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sundeep Agrawal', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109218241', 'display_name': 'Yang-Min Ning', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}, {'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yang-min Ning', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017896955', 'display_name': 'V. Ellen Maher', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'V. Ellen Maher', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083318636', 'display_name': 'Laura L. Fernandes', 'orcid': 'https://orcid.org/0000-0002-5986-3885'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Laura L. Fernandes', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090151170', 'display_name': 'Stella W. Karuri', 'orcid': 'https://orcid.org/0000-0001-7544-9345'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Stella Karuri', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043067852', 'display_name': 'Shenghui Tang', 'orcid': 'https://orcid.org/0000-0002-0437-665X'}, 'institutions': [{'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}, {'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Shenghui Tang', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110134625', 'display_name': 'Rajeshwari Sridhara', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rajeshwari Sridhara', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044644162', 'display_name': 'Jason Schroeder', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jason Schroeder', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074097054', 'display_name': 'Kirsten B. Goldberg', 'orcid': 'https://orcid.org/0000-0001-8659-1240'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kirsten B. Goldberg', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018934213', 'display_name': 'Amna Ibrahim', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}, {'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Amna Ibrahim', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103828801', 'display_name': 'Amy E. McKee', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Amy E. McKee', 'raw_affiliation_strings': ['Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051520990', 'display_name': 'Richard Pazdur', 'orcid': 'https://orcid.org/0000-0002-4771-9923'}, 'institutions': [{'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard Pazdur', 'raw_affiliation_strings': ['Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1320320070']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5004000071', 'display_name': 'Julia A. Beaver', 'orcid': 'https://orcid.org/0000-0002-0725-2863'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Julia A. Beaver', 'raw_affiliation_strings': ['Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5040090615'], 'corresponding_institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070'], 'apc_list': {'value': 3494, 'currency': 'USD', 'value_usd': 3494, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 24.588, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 174, 'citation_normalized_percentile': {'value': 0.897508, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '24', 'issue': '4', 'first_page': '563', 'last_page': '569'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10458', 'display_name': 'Bladder and Urothelial Cancer Treatments', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10458', 'display_name': 'Bladder and Urothelial Cancer Treatments', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12695', 'display_name': 'Urinary and Genital Oncology Studies', 'score': 0.9972, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9963, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/atezolizumab', 'display_name': 'Atezolizumab', 'score': 0.9746911}, {'id': 'https://openalex.org/keywords/metastatic-urothelial-carcinoma', 'display_name': 'Metastatic Urothelial Carcinoma', 'score': 0.6687936}, {'id': 'https://openalex.org/keywords/clinical-endpoint', 'display_name': 'Clinical endpoint', 'score': 0.4175303}], 'concepts': [{'id': 'https://openalex.org/C2775949291', 'wikidata': 'https://www.wikidata.org/wiki/Q20707748', 'display_name': 'Atezolizumab', 'level': 5, 'score': 0.9746911}, {'id': 'https://openalex.org/C2780057760', 'wikidata': 'https://www.wikidata.org/wiki/Q13896859', 'display_name': 'Pembrolizumab', 'level': 4, 'score': 0.96891356}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9148724}, {'id': 'https://openalex.org/C2911057145', 'wikidata': 'https://www.wikidata.org/wiki/Q2501186', 'display_name': 'Metastatic Urothelial Carcinoma', 'level': 5, 'score': 0.6687936}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.6046139}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.54974025}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.5150082}, {'id': 'https://openalex.org/C2778239845', 'wikidata': 'https://www.wikidata.org/wiki/Q412415', 'display_name': 'Cisplatin', 'level': 3, 'score': 0.508668}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.45912468}, {'id': 'https://openalex.org/C203092338', 'wikidata': 'https://www.wikidata.org/wiki/Q1340863', 'display_name': 'Clinical endpoint', 'level': 3, 'score': 0.4175303}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.2838341}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.24938205}, {'id': 'https://openalex.org/C2780352672', 'wikidata': 'https://www.wikidata.org/wiki/Q504775', 'display_name': 'Bladder cancer', 'level': 3, 'score': 0.17779985}, {'id': 'https://openalex.org/C3019882237', 'wikidata': 'https://www.wikidata.org/wiki/Q2501186', 'display_name': 'Urothelial carcinoma', 'level': 4, 'score': 0.13998145}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D060890', 'descriptor_name': 'B7-H1 Antigen', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D002945', 'descriptor_name': 'Cisplatin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D014571', 'descriptor_name': 'Urologic Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D060890', 'descriptor_name': 'B7-H1 Antigen', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D060890', 'descriptor_name': 'B7-H1 Antigen', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015331', 'descriptor_name': 'Cohort Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005500', 'descriptor_name': 'Follow-Up Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018570', 'descriptor_name': 'Risk Assessment', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014481', 'descriptor_name': 'United States', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014486', 'descriptor_name': 'United States Food and Drug Administration', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014571', 'descriptor_name': 'Urologic Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D014571', 'descriptor_name': 'Urologic Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.2018-0084', 'pdf_url': 'https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2018-0084', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc6459239', 'pdf_url': 'https://europepmc.org/articles/pmc6459239?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459239', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30541754', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.2018-0084', 'pdf_url': 'https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2018-0084', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.69, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 12, 'referenced_works': ['https://openalex.org/W1857682357', 'https://openalex.org/W2060619877', 'https://openalex.org/W2120955645', 'https://openalex.org/W2148562299', 'https://openalex.org/W2152762320', 'https://openalex.org/W2235523093', 'https://openalex.org/W2259411705', 'https://openalex.org/W2397377428', 'https://openalex.org/W2606494852', 'https://openalex.org/W2738200477', 'https://openalex.org/W2769394597', 'https://openalex.org/W2793539832'], 'related_works': ['https://openalex.org/W4283830979', 'https://openalex.org/W4224282955', 'https://openalex.org/W4212927231', 'https://openalex.org/W4206430965', 'https://openalex.org/W3031689938', 'https://openalex.org/W2969038597', 'https://openalex.org/W2903848939', 'https://openalex.org/W2785808209', 'https://openalex.org/W2775971156', 'https://openalex.org/W2473036963'], 'abstract_inverted_index': {'Abstract': [0], 'The': [1, 60, 87, 106, 180, 224], 'U.S.': [2], 'Food': [3], 'and': [4, 13, 17, 46, 57, 78, 98, 124, 169, 184, 205, 214, 229, 259, 317], 'Drug': [5], 'Administration': [6], '(FDA)': [7], 'granted': [8], 'accelerated': [9, 209, 225], 'approval': [10, 210], 'to': [11], 'atezolizumab': [12, 77, 183, 228], 'pembrolizumab': [14, 185, 230], 'in': [15, 50, 74, 83, 95, 147, 186, 295], 'April': [16], 'May': [18], '2017,': [19], 'respectively,': [20], 'for': [21, 37, 144, 155, 159, 166, 182, 222, 231, 243, 292, 303, 307, 314], 'the': [22, 51, 142, 201, 208, 215, 219, 239, 287, 290], 'treatment': [23], 'of': [24, 90, 103, 109, 129, 178, 211, 218, 227, 262, 323], 'patients': [25, 75, 84, 156, 187, 233, 304], 'with': [26, 115, 234, 264, 270], 'locally': [27], 'advanced': [28, 235], 'or': [29, 163, 311], 'metastatic': [30], 'urothelial': [31, 236], 'carcinoma': [32, 237], 'who': [33, 188], 'are': [34, 126, 152, 299], 'not': [35, 93, 157, 164, 195, 305, 312], 'eligible': [36, 158, 165, 306, 313], 'cisplatin-containing': [38, 167, 315], 'chemotherapy.': [39], 'These': [40, 247], 'approvals': [41, 226, 248], 'were': [42, 100, 112, 249], 'based': [43, 250, 276], 'on': [44, 133, 251, 277], 'efficacy': [45], 'safety': [47, 107], 'data': [48, 206], 'demonstrated': [49], 'two': [52, 282], 'single-arm': [53, 252], 'trials,': [54, 139, 286], 'IMvigor210': [55], '(atezolizumab)': [56], 'KEYNOTE-052': [58], '(pembrolizumab).': [59], 'primary': [61], 'endpoint,': [62], 'confirmed': [63], 'objective': [64, 256], 'response': [65, 91, 257, 263], 'rate,': [66], 'was': [67, 92], '23.5%': [68], '(95%': [69, 80], 'confidence': [70], 'interval': [71], '[CI]:': [72], '16.2%–32.2%)': [73], 'receiving': [76, 85], '28.6%': [79], 'CI:': [81], '24.1%–33.5%)': [82], 'pembrolizumab.': [86], 'median': [88], 'duration': [89], 'reached': [94], 'either': [96, 302], 'study': [97], 'responses': [99], 'seen': [101], 'regardless': [102], 'PD-L1': [104], 'status.': [105], 'profiles': [108], 'both': [110, 145, 212, 293], 'drugs': [111, 151], 'generally': [113], 'consistent': [114], 'approved': [116, 241], 'agents': [117, 146, 213, 294], 'targeting': [118], 'PD-1/PD-L1.': [119], 'Two': [120], 'ongoing': [121, 283], 'trials': [122, 253], '(IMvigor130': [123], 'KEYNOTE-361)': [125], 'verifying': [127], 'benefit': [128], 'these': [130, 138], 'drugs.': [131], 'Based': [132], 'concerning': [134, 278], 'preliminary': [135, 279], 'reports': [136, 280], 'from': [137, 281], 'FDA': [140, 202, 288], 'revised': [141, 289], 'indications': [143, 181], 'cisplatin-ineligible': [148, 232, 296], 'patients.': [149, 297], 'Both': [150, 298], 'now': [153, 300], 'indicated': [154, 301], 'any': [160, 308], 'platinum-containing': [161, 309], 'chemotherapy': [162, 168, 273, 310, 316], 'whose': [170, 318], 'tumors/infiltrating': [171], 'immune': [172], 'cells': [173], 'express': [174], 'a': [175], 'high': [176, 321], 'level': [177], 'PD-L1.': [179, 324], 'have': [189, 194, 320], 'received': [190], 'prior': [191], 'platinum-based': [192], 'therapy': [193], 'been': [196], 'changed.': [197], 'This': [198], 'article': [199], 'summarizes': [200], 'thought': [203], 'process': [204], 'supporting': [207], 'subsequent': [216], 'revision': [217], 'indications.': [220], 'Implications': [221], 'Practice': [223], 'represent': [238], 'first': [240], 'therapies': [242], 'this': [244], 'patient': [245], 'population.': [246], 'demonstrating': [254], 'reasonable': [255], 'rates': [258], 'favorable': [260], 'durations': [261], 'an': [265], 'acceptable': [266], 'toxicity': [267], 'profile': [268], 'compared': [269], 'available': [271], 'non-cisplatin-containing': [272], 'regimens.': [274], 'However,': [275], 'phase': [284], 'III': [285], 'indication': [291], 'tumors': [319], 'expression': [322]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2903848939', 'counts_by_year': [{'year': 2024, 'cited_by_count': 26}, {'year': 2023, 'cited_by_count': 25}, {'year': 2022, 'cited_by_count': 28}, {'year': 2021, 'cited_by_count': 38}, {'year': 2020, 'cited_by_count': 43}, {'year': 2019, 'cited_by_count': 11}], 'updated_date': '2024-12-24T08:29:59.940777', 'created_date': '2018-12-22'}